Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | SRD5A2 | P31213 | 11/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.36 |
| ▸ | SRD5A1 | P18405 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6897611 | 1.00 | ESR1 (0.42) | ESR1ARESR2SRD5A2CYP19A1 | |
| SCHEMBL6899595 | 0.80 | ESR1 (0.46) | ESR1ARESR2SRD5A2CYP19A1 | |
| SCHEMBL7100236 | 0.80 | ESR1 (0.46) | ESR1ARESR2SRD5A2CYP19A1 | |
| SCHEMBL6899597 | 0.80 | ESR1 (0.46) | ESR1ARESR2SRD5A2CYP19A1 | |
| SCHEMBL9806099 | 0.79 | SHBG (0.56) | ESR1ARESR2 | |
| SCHEMBL10898740 | 0.79 | SHBG (0.56) | ESR1ARESR2 | |
| SCHEMBL5310190 | 0.79 | CYP19A1 (0.60) | SRD5A2CYP19A1 | |
| SCHEMBL8245517 | 0.79 | CYP19A1 (0.60) | SRD5A2CYP19A1 | |
| SCHEMBL1044379 | 0.79 | CYP19A1 (0.60) | SRD5A2CYP19A1 | |
| SCHEMBL10380160 | 0.78 | ESR1 (0.45) | ESR1ARESR2SRD5A2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0891188-A4 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | PHERIN PHARM INC (US) | 2004-09-01 | — | — | EP | disclosed |
| US-6331534-B1 | ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN | PHERIN PHARMACEUTICALS, INC. | 2001-12-18 | — | — | US | disclosed |
| EP-0775154-A4 | PREGNANES AND CHOLANES AS NEUROCHEMICAL INITIATORS OF CHANGE IN HYPOTHALAMIC FUNCTION | PHERIN CORP (US) | 2001-05-09 | — | — | EP | disclosed |
| US-6117860-A | NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY | PHERIN PHARMACEUTICALS, INC. (US) | 2000-09-12 | — | — | US | disclosed |
| US-6066627-A | ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE | PHERIN CORPORATION (US) | 2000-05-23 | — | — | US | disclosed |
| US-6057439-A | EPOXYSTEROIDS | PHERIN CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| US-5994333-A | NASAL ADMINISTERING | PHERIN CORPORATION (US) | 1999-11-30 | — | — | US | disclosed |
| EP-0891188-A1 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | Pherin Pharmaceuticals, Inc. (US) | 1999-01-20 | — | — | EP | disclosed |
| WO-1997036596-A1 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | PHERIN PHARMACEUTICALS, INC. (US) | 1997-10-09 | — | — | WO | disclosed |
| EP-0775154-A1 | PREGNANES AND CHOLANES AS NEUROCHEMICAL INITIATORS OF CHANGE IN HYPOTHALAMIC FUNCTION | PHERIN CORPORATION (US) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996004296-A1 | PREGNANES AND CHOLANES AS NEUROCHEMICAL INITIATORS OF CHANGE IN HYPOTHALAMIC FUNCTION | PHERIN CORPORATION (US) | 1996-02-15 | — | — | WO | disclosed |